发文分析
近年国家/地区发文量统计
| 国家/地区 | 数量 |
|---|---|
| USA | 68 |
| CHINA MAINLAND | 54 |
| England | 36 |
| GERMANY (FED REP GER) | 24 |
| Italy | 23 |
| France | 22 |
| Spain | 20 |
| Australia | 17 |
| Japan | 17 |
| Canada | 12 |
近年机构发文量统计
| 机构 | 数量 |
|---|---|
| ASSISTANCE PUBLIQUE HOPITAUX PARIS (APHP) | 13 |
| IMPERIAL COLLEGE LONDON | 12 |
| MAYO CLINIC | 11 |
| TEL AVIV UNIVERSITY | 11 |
| CIBER - CENTRO DE INVESTIGACION BIOMEDICA EN R... | 10 |
| SUN YAT SEN UNIVERSITY | 10 |
| CHAIM SHEBA MEDICAL CENTER | 9 |
| INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERC... | 8 |
| SHANGHAI JIAO TONG UNIVERSITY | 8 |
| UNIVERSIDADE DO PORTO | 8 |
近年文章引用他刊数据
| 文章名称 | 引用次数 |
|---|---|
| Immunogenicity of biologics in inflammatory bowel diseas... | 30 |
| The gut virome: the 'missing link' between gut bacteria ... | 24 |
| Long-term use of proton-pump inhibitors and risk of gast... | 20 |
| Proton-pump inhibitors among adults: a nationwide drug-u... | 19 |
| New biologics and small molecules in inflammatory bowel ... | 19 |
| Insights into the role of fecal microbiota transplantati... | 17 |
| The controversial role of Enterococcus faecalis in color... | 16 |
| Cholestatic liver diseases: new targets, new therapies | 14 |
| Therapeutic drug monitoring of vedolizumab in inflammato... | 12 |
| Inflammatory bowel disease: towards a personalized medic... | 11 |
近年被他刊引用数据
| 期刊名称 | 引用次数 |
|---|---|
| WORLD J GASTROENTERO | 31 |
| INT J MOL SCI | 27 |
| NUTRIENTS | 25 |
| MEDICINE | 24 |
| THER ADV GASTROENTER | 22 |
| EXPERT REV GASTROENT | 20 |
| ALIMENT PHARM THER | 17 |
| SCI REP-UK | 17 |
| CELLS-BASEL | 16 |
| GASTROENTEROLOGY | 14 |